Good Therapeutics, a Seattle startup, has raised $8 million toward advancing therapeutic proteins aimed at helping cancer patients.
With 22 employees total, the company is currently selecting a clinical candidate for its IL-2 program which has been showing promising results.
READ THE STORY at GeekWire »